Suppr超能文献

p53 状态在基质成纤维细胞中调节肿瘤生长依赖于 SDF1 的方式。

p53 status in stromal fibroblasts modulates tumor growth in an SDF1-dependent manner.

机构信息

Department of Biological Regulation, The Weizmann Institute, Rehovot, Israel.

出版信息

Cancer Res. 2010 Dec 1;70(23):9650-8. doi: 10.1158/0008-5472.CAN-10-1146. Epub 2010 Oct 15.

Abstract

The p53 tumor suppressor exerts a variety of cell-autonomous effects that are aimed to thwart tumor development. In addition, however, there is growing evidence for cell nonautonomous tumor suppressor effects of p53. In the present study, we investigated the impact of stromal p53 on tumor growth. Specifically, we found that ablation of p53 in fibroblasts enabled them to promote more efficiently the growth of tumors initiated by PC3 prostate cancer-derived cells. This stimulatory effect was dependent on the increased expression of the chemokine SDF-1 in the p53-deficient fibroblasts. Notably, fibroblasts harboring mutant p53 protein were more effective than p53-null fibroblasts in promoting tumor growth. The presence of either p53-null or p53-mutant fibroblasts led also to a markedly elevated rate of metastatic spread of the PC3 tumors. These findings implicate p53 in a cell nonautonomous tumor suppressor role within stromal fibroblasts, through suppressing the production of tumor stimulatory factors by these cells. Moreover, expression of mutant p53 by tumor stroma fibroblasts might exert a gain of function effect, further accelerating tumor development.

摘要

抑癌基因 p53 可发挥多种细胞自主效应,旨在阻止肿瘤的发生。然而,目前越来越多的证据表明 p53 具有非细胞自主的肿瘤抑制作用。在本研究中,我们研究了基质 p53 对肿瘤生长的影响。具体而言,我们发现成纤维细胞中 p53 的缺失使其能够更有效地促进由 PC3 前列腺癌细胞引发的肿瘤生长。这种刺激作用依赖于 p53 缺陷型成纤维细胞中趋化因子 SDF-1 的表达增加。值得注意的是,携带突变型 p53 蛋白的成纤维细胞比 p53 缺失型成纤维细胞更有效地促进肿瘤生长。p53 缺失型或突变型成纤维细胞的存在也导致 PC3 肿瘤的转移扩散速度明显加快。这些发现提示 p53 通过抑制这些细胞产生肿瘤刺激因子,在基质成纤维细胞中发挥非细胞自主的肿瘤抑制作用。此外,肿瘤基质成纤维细胞中突变型 p53 的表达可能发挥功能获得效应,进一步加速肿瘤的发展。

相似文献

1
p53 status in stromal fibroblasts modulates tumor growth in an SDF1-dependent manner.
Cancer Res. 2010 Dec 1;70(23):9650-8. doi: 10.1158/0008-5472.CAN-10-1146. Epub 2010 Oct 15.
4
Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis.
Cancer Res. 2005 Mar 1;65(5):1627-30. doi: 10.1158/0008-5472.CAN-04-3791.
6
Asporin is a stromally expressed marker associated with prostate cancer progression.
Br J Cancer. 2017 Mar 14;116(6):775-784. doi: 10.1038/bjc.2017.15. Epub 2017 Feb 2.
7
Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.
Cancer Res. 2012 Oct 1;72(19):5130-40. doi: 10.1158/0008-5472.CAN-12-1949. Epub 2012 Jul 31.
8
Inhibition of Hsp90 via 17-DMAG induces apoptosis in a p53-dependent manner to prevent medulloblastoma.
Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17037-42. doi: 10.1073/pnas.0902880106. Epub 2009 Sep 23.
9
Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction.
J Exp Clin Cancer Res. 2010 Jun 22;29(1):80. doi: 10.1186/1756-9966-29-80.
10
p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase.
Mol Cancer Res. 2010 Aug;8(8):1126-41. doi: 10.1158/1541-7786.MCR-10-0174. Epub 2010 Jul 20.

引用本文的文献

1
Tumor suppressor genes in the tumor microenvironment.
Dis Model Mech. 2025 Mar 1;18(3). doi: 10.1242/dmm.052049. Epub 2025 Mar 20.
2
Mutant p53-Mediated Tumor Secretome: Bridging Tumor Cells and Stromal Cells.
Genes (Basel). 2024 Dec 17;15(12):1615. doi: 10.3390/genes15121615.
4
Recent Advances and Mechanism of Nanomaterials Promoting Tumor Metastasis.
Environ Health (Wash). 2023 Nov 9;1(6):367-382. doi: 10.1021/envhealth.3c00132. eCollection 2023 Dec 15.
5
p53 at the crossroads of tumor immunity.
Nat Cancer. 2024 Jul;5(7):983-995. doi: 10.1038/s43018-024-00796-z. Epub 2024 Jul 15.
7
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy.
Cancer Commun (Lond). 2024 Mar;44(3):297-360. doi: 10.1002/cac2.12520. Epub 2024 Feb 4.
8
TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress.
Mol Biol Rep. 2024 Jan 25;51(1):205. doi: 10.1007/s11033-023-09097-7.
10
Regulated secretion of mutant p53 negatively affects T lymphocytes in the tumor microenvironment.
Oncogene. 2024 Jan;43(2):92-105. doi: 10.1038/s41388-023-02886-1. Epub 2023 Nov 11.

本文引用的文献

1
Mutant p53 gain-of-function in cancer.
Cold Spring Harb Perspect Biol. 2010 Feb;2(2):a001107. doi: 10.1101/cshperspect.a001107.
2
Mutant p53 drives invasion by promoting integrin recycling.
Cell. 2009 Dec 24;139(7):1327-41. doi: 10.1016/j.cell.2009.11.026.
3
Involvement of stromal p53 in tumor-stroma interactions.
Semin Cell Dev Biol. 2010 Feb;21(1):47-54. doi: 10.1016/j.semcdb.2009.11.006. Epub 2009 Nov 13.
5
Clonal mutations in the cancer-associated fibroblasts: the case against genetic coevolution.
Cancer Res. 2009 Sep 1;69(17):6765-8; discussion 6769. doi: 10.1158/0008-5472.CAN-08-4253. Epub 2009 Aug 25.
6
Genomic alterations in tumor stroma.
Cancer Res. 2009 Sep 1;69(17):6759-64. doi: 10.1158/0008-5472.CAN-09-0985. Epub 2009 Aug 25.
7
When mutants gain new powers: news from the mutant p53 field.
Nat Rev Cancer. 2009 Oct;9(10):701-13. doi: 10.1038/nrc2693. Epub 2009 Aug 20.
8
Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1.
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12115-20. doi: 10.1073/pnas.0903120106. Epub 2009 Jul 6.
9
A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis.
Cell. 2009 Apr 3;137(1):87-98. doi: 10.1016/j.cell.2009.01.039.
10
CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth.
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3414-9. doi: 10.1073/pnas.0813144106. Epub 2009 Feb 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验